Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)
Status:
Completed
Trial end date:
2013-05-09
Target enrollment:
Participant gender:
Summary
This study will test the hypothesis that preservative-free tafluprost (MK-2452) is
non-inferior to preservative-free timolol maleate with respect to the diurnal intraocular
pressure (IOP) change from baseline after 4 weeks of therapy in participants with open-angle
glaucoma or ocular hypertension.